57 related articles for article (PubMed ID: 22076042)
1. Efficient antitumor effects of carrier cells loaded with a fiber-substituted conditionally replicating adenovirus on CAR-negative tumor cells.
Iguchi K; Sakurai F; Tomita K; Katayama K; Yamaguchi T; Kawabata K; Tagawa M; Kawabata M; Shirakawa T; Mizuguchi H
Cancer Gene Ther; 2012 Feb; 19(2):118-25. PubMed ID: 22076042
[TBL] [Abstract][Full Text] [Related]
2. A novel bladder cancer - specific oncolytic adenovirus by CD46 and its effect combined with cisplatin against cancer cells of CAR negative expression.
Cao W; Tian J; Li C; Gao Y; Liu X; Lu J; Wang Y; Wang Z; Svatek RS; Rodriguez R
Virol J; 2017 Aug; 14(1):149. PubMed ID: 28789701
[TBL] [Abstract][Full Text] [Related]
3. Conditionally replicating adenovirus improves gene replication efficiency and anticancer effect of E1-deleted adenovirus carrying TRAIL in head and neck squamous cell carcinoma.
Shim SH; Lee CT; Hun Hah J; Lee JJ; Park SW; Heo DS; Sung MW
Cancer Sci; 2010 Feb; 101(2):482-7. PubMed ID: 19922505
[TBL] [Abstract][Full Text] [Related]
4. hTERT-promoter-dependent oncolytic adenovirus enhances the transduction and therapeutic efficacy of replication-defective adenovirus vectors in pancreatic cancer cells.
Onimaru M; Ohuchida K; Mizumoto K; Nagai E; Cui L; Toma H; Takayama K; Matsumoto K; Hashizume M; Tanaka M
Cancer Sci; 2010 Mar; 101(3):735-42. PubMed ID: 20059477
[TBL] [Abstract][Full Text] [Related]
5. Targeting lung cancer using an infectivity enhanced CXCR4-CRAd.
Zhu ZB; Rivera AA; Makhija SK; Lu B; Wang M; Izumi M; Cerfolio RJ; Stoff-Khalili MA; Zhou F; Takayama K; Siegal GP; Curiel DT
Lung Cancer; 2007 Feb; 55(2):145-56. PubMed ID: 17113184
[TBL] [Abstract][Full Text] [Related]
6. Safety profiles and antitumor efficacy of oncolytic adenovirus coated with bioreducible polymer in the treatment of a CAR negative tumor model.
Jung SJ; Kasala D; Choi JW; Lee SH; Hwang JK; Kim SW; Yun CO
Biomacromolecules; 2015 Jan; 16(1):87-96. PubMed ID: 25400213
[TBL] [Abstract][Full Text] [Related]
7. Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector.
Shayakhmetov DM; Papayannopoulou T; Stamatoyannopoulos G; Lieber A
J Virol; 2000 Mar; 74(6):2567-83. PubMed ID: 10684271
[TBL] [Abstract][Full Text] [Related]
8. Enhanced cancer cell killing by truncated E2F-1 used in combination with oncolytic adenovirus.
Gomez-Gutierrez JG; Rao XM; Zhou HS; McMasters KM
Virology; 2012 Nov; 433(2):538-47. PubMed ID: 23021422
[TBL] [Abstract][Full Text] [Related]
9. Potent antitumor efficacy of human dental pulp stem cells armed with YSCH-01 oncolytic adenovirus.
He X; Yao W; Zhu JD; Jin X; Liu XY; Zhang KJ; Zhao SL
J Transl Med; 2023 Oct; 21(1):688. PubMed ID: 37789452
[TBL] [Abstract][Full Text] [Related]
10. Ad5/3 is able to avoid neutralization by binding to erythrocytes and lymphocytes.
Zafar S; Quixabeira DCA; Kudling TV; Cervera-Carrascon V; Santos JM; Grönberg-Vähä-Koskela S; Zhao F; Aronen P; Heiniö C; Havunen R; Sorsa S; Kanerva A; Hemminki A
Cancer Gene Ther; 2021 May; 28(5):442-454. PubMed ID: 32920593
[TBL] [Abstract][Full Text] [Related]
11. Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth.
Tedcastle A; Illingworth S; Brown A; Seymour LW; Fisher KD
Mol Ther; 2016 Apr; 24(4):796-804. PubMed ID: 26708004
[TBL] [Abstract][Full Text] [Related]
12. Targeted and shielded adenovectors for cancer therapy.
Hedley SJ; Chen J; Mountz JD; Li J; Curiel DT; Korokhov N; Kovesdi I
Cancer Immunol Immunother; 2006 Nov; 55(11):1412-9. PubMed ID: 16612598
[TBL] [Abstract][Full Text] [Related]
13. Adenoviral-mediated gene transfer in lymphocytes.
Leon RP; Hedlund T; Meech SJ; Li S; Schaack J; Hunger SP; Duke RC; DeGregori J
Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13159-64. PubMed ID: 9789058
[TBL] [Abstract][Full Text] [Related]
14. Generation and evaluation of a chimeric antibody against coxsackievirus and adenovirus receptor for cancer therapy.
Sakamoto S; Inoue H; Kaneko MK; Ogasawara S; Kajikawa M; Urano S; Ohba SI; Kato Y; Kawada M
Cancer Sci; 2019 Nov; 110(11):3595-3602. PubMed ID: 31512325
[TBL] [Abstract][Full Text] [Related]
15. Transduction and oncolytic profile of a potent replication-competent adenovirus 11p vector (RCAd11pGFP) in colon carcinoma cells.
Silver J; Mei YF
PLoS One; 2011 Mar; 6(3):e17532. PubMed ID: 21455297
[TBL] [Abstract][Full Text] [Related]
16. The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F.
Roelvink PW; Lizonova A; Lee JG; Li Y; Bergelson JM; Finberg RW; Brough DE; Kovesdi I; Wickham TJ
J Virol; 1998 Oct; 72(10):7909-15. PubMed ID: 9733828
[TBL] [Abstract][Full Text] [Related]
17. Enhanced CRAd activity using enhancer motifs driven by a nucleosome positioning sequence.
Bravo S; Núñez F; Cruzat F; Cafferata EG; De Ferrari GV; Montecino M; Podhajcer OL
Mol Ther; 2013 Jul; 21(7):1403-12. PubMed ID: 23712038
[TBL] [Abstract][Full Text] [Related]
18. Multiple Treatment Cycles of Neural Stem Cell Delivered Oncolytic Adenovirus for the Treatment of Glioblastoma.
Batalla-Covello J; Ngai HW; Flores L; McDonald M; Hyde C; Gonzaga J; Hammad M; Gutova M; Portnow J; Synold T; Curiel DT; Lesniak MS; Aboody KS; Mooney R
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944938
[TBL] [Abstract][Full Text] [Related]
19. Human Species D Adenoviruses Isolated from Diarrheal Feces Show Low Infection Rates in Primary Nasal Epithelial Cells.
Aydin M; Schellhorn S; Wirth S; Zhang W; Ehrhardt A
Children (Basel); 2021 Jun; 8(7):. PubMed ID: 34208817
[TBL] [Abstract][Full Text] [Related]
20. Nonhuman Primate Adenoviruses of the Human Adenovirus B Species Are Potent and Broadly Acting Oncolytic Vector Candidates.
Bots STF; Kemp V; Cramer SJ; van den Wollenberg DJM; Hornsveld M; Lamfers MLM; van der Pluijm G; Hoeben RC
Hum Gene Ther; 2022 Mar; 33(5-6):275-289. PubMed ID: 34861769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
